GlaxoSmithKline AG - Hiberix, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung Swissmedic Registration 00603 Sequence 01 Product name Hiberix Description Pulver und Lösungsmittel zur Herstellung einer Injektionslösung ATC-Classification J07AG01 ATC-Description Haemophilus Influenzae B, Purified Antigen Conjugated Introduction of Sequence 15.09.1997
Composition Praeparatio cryodesiccata: polysaccharida haemophili influenzae typus B 20752 conjugata cum toxoido tetani 10 µg, lactosum, pro praeparatione.
Solvens: natrii chloridum corresp. natrium 1.77 mg, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml. Packungsbestandteile Active Agent Dose Haemophilus Influenzae b Polysaccharida (Prp) 10 mcg
BAG: Active Agent Dose Haemophilus Influenzae b Polysaccharida (Prp) 10 mcg
Label Praeparatio cryodesiccata:
Galenic Form Lyophilisate and solvent Excipiens BAG: Active Agent Dose Haemophilus Influenzae b Polysaccharida (Prp) 10 mcg
Inactive agents Dose Conjugata cum Toxoido Tetani 10 µg Lactosum Polysaccharida Haemophili Influenzae Typus B 20752
Label Solvens
Galenic Form Lyophilisate and solvent Excipiens BAG: Active Agent Dose Haemophilus Influenzae b Polysaccharida (Prp) 10 mcg
Inactive agents Sodium Chloride
Package number Package Size EFP CP Category SL Out of trade (MedRef) 001 Set(s) 16.16 34.00 B SL Yes
